Literature DB >> 17015793

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.

Tom D J Smilde1, Dirk J van Veldhuisen, Gerjan Navis, Adriaan A Voors, Hans L Hillege.   

Abstract

BACKGROUND: Renal function is an important risk marker for morbidity and mortality in chronic heart failure (CHF) and is often estimated with the use of creatinine-based formulas. However, these formulas have never been validated in a wide range of CHF patients. We validated 3 commonly used formulas estimating glomerular filtration rate (GFR) with true GFR in CHF patients. Furthermore, we compared the prognostic value of these formulas for cardiovascular outcome with that of true GFR during 12 months of follow-up. METHODS AND
RESULTS: In 110 CHF patients (age, 57+/-11.7 years; left ventricular ejection fraction, 0.27+/-0.09; NYHA class, 2.5+/-0.9), we measured 125I-iothalamate clearance. Cockcroft-Gault (GFR(cg)), Modification of Diet in Renal Disease (MDRD), and simplified MDRD (sMDRD) equations were used as creatinine-based renal function estimations. Furthermore, 24-hour creatinine clearance (CrCl) was determined. CrCl and GFR(cg) were the most accurate. MDRD was most precise formula, although it was also highly biased. All formulas overestimated in the lower ranges and underestimated in the upper ranges of the GFR corrected for body surface area. The predictive performance of the formulas was best in severe CHF (NYHA classes III and IV). The prognostic value of CrCl and MDRD for cardiovascular outcome was comparable to that of GFR, the sMDRD was slightly less, and the GFR(cg) had a significantly worse prognostic value.
CONCLUSIONS: In the more severe ranges of CHF, creatinine-based formulas and CrCl corrected for body surface area appeared to be more precise and accurate in estimating true GFR corrected for body surface area. The MDRD formula is the most precise and has a good prognostic value, whereas the sMDRD is slightly less accurate but uses fewer parameters, which makes this formula a practical alternative in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015793     DOI: 10.1161/CIRCULATIONAHA.105.610642

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  55 in total

1.  Sex differences in new-onset heart failure.

Authors:  Sven Meyer; Frank P Brouwers; Adriaan A Voors; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Pim van der Harst; Michiel Rienstra; Isabelle C van Gelder; Dirk J van Veldhuisen; Wiek H van Gilst; Peter van der Meer
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

Review 2.  Emerging therapies for heart failure: renal mechanisms and effects.

Authors:  Amir Kazory; Edward A Ross
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

3.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

4.  Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment.

Authors:  Christine Heitmeyer; Birgit Hölscher; Manfred Fobker; Günter Breithardt; Martin Hausberg; Holger Reinecke
Journal:  Clin Cardiol       Date:  2010-10-26       Impact factor: 2.882

5.  Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.

Authors:  Matthias Dupont; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2012-08-16       Impact factor: 8.790

Review 6.  Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.

Authors:  Maria Rosa Costanzo; Mariell Jessup
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 7.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12

8.  High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine.

Authors:  O Kenrik Duru; Roberto B Vargas; Dulcie Kermah; Allen R Nissenson; Keith C Norris
Journal:  J Gen Intern Med       Date:  2008-11-06       Impact factor: 5.128

9.  Activation of a novel natriuretic endocrine system in humans with heart failure.

Authors:  Hafid Narayan; Noor Mohammed; Paulene A Quinn; Iain B Squire; Joan E Davies; Leong L Ng
Journal:  Clin Sci (Lond)       Date:  2010-03       Impact factor: 6.124

10.  Renal dysfunction is associated with shorter telomere length in heart failure.

Authors:  Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Journal:  Clin Res Cardiol       Date:  2009-07-15       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.